RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Rosiglitazone is effective and well-tolerated in a range of therapeutic regimens during daily practice in patients with type 2 diabetes.

Rosiglitazone is effective and well-tolerated in a range of therapeutic regimens during daily practice in patients with type 2 diabetes.

Add to Collection
2006 Sep Others Fist_Author_Year_PM

Full Author : ['Rosak, C', 'Standl, E', 'Reblin, T', 'Stammer, H', 'Seidel, D K']
Journal Title : International journal of clinical practice
Chapter : Section3
Journal Year : 2006
Cited by : Not Available

Subjects (N = 22,808) with inadequately controlled type 2 diabetes mellitus (T2DM) were included in a large 6-month observational study in Germany. Rosiglitazone (RSG) was added to existing therapy in line with daily practice, with 19,962 subjects evaluat.....

Keywords : ["type diabetes", "therapeutic regimen", "daily practice", "welltolerate", "rosiglitazone", "range", "patient", "effective"]